Torrent Pharmaceuticals · NSE: TORNTPHARM · BSE: 500420
Q1 FY20 results · Apr–Jun 2019
Torrent Pharmaceuticals reported revenue from operations of ₹2,022.00 crore (up 8.0% from Q1 FY19) and net profit of ₹216.00 crore (up 32.5% from Q1 FY19) for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,022.00 | 1,872.00 | +8.0% | 1,856.00 | +8.9% |
| Other income | 20.00 | 27.00 | −25.9% | 17.00 | +17.6% |
| Total income | 2,042.00 | 1,899.00 | +7.5% | 1,873.00 | +9.0% |
| Profit before tax | 279.00 | 232.00 | +20.3% | (150.00) | Turned profit |
| Net profit for the period | 216.00 | 163.00 | +32.5% | (152.00) | Turned profit |
| EPS, basic (₹) | 12.74 | 9.66 | +31.9% | (8.95) | Turned profit |
| Net margin (%) | 10.7 | 8.7 | -8.2 |
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,603.00 | 1,452.00 | +10.4% | 1,357.00 | +18.1% |
| Other income | 31.00 | 34.00 | −8.8% | 227.00 | −86.3% |
| Total income | 1,634.00 | 1,486.00 | +10.0% | 1,584.00 | +3.2% |
| Profit before tax | 277.00 | 188.00 | +47.3% | 255.00 | +8.6% |
| Net profit for the period | 223.00 | 122.00 | +82.8% | 164.00 | +36.0% |
| EPS, basic (₹) | 13.18 | 7.21 | +82.8% | 9.73 | +35.5% |
| Net margin (%) | 13.9 | 8.4 | 12.1 |
Consolidated
- Filed with BSE
- 24 Jul 2019, 12:32 IST
- Board meeting
- 23 Jul 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 24 Jul 2019, 12:32 IST
- Board meeting
- 23 Jul 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Audited
- Source
- XBRL filing on BSE